• Business Operations and Strategy

Eli Lilly's GLP-1 Opportunity: Transformative Growth vs. Manufacturing and Counterfeit Risks

While Lilly's pipeline advantages position it for market dominance, supply chain vulnerabilities and illicit competition create significant downside scenarios for investors.